Universal Beteiligungs und Servicegesellschaft mbH Invests $625,000 in Privia Health Group, Inc. (NASDAQ:PRVA)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH made a new investment of approximately $625,000 in Privia Health Group, purchasing 27,860 shares in the first quarter.
• Analysts maintain a generally positive outlook on Privia Health Group, with an average rating of "Buy" and a consensus target price of $28.38.
• Privia Health Group's stock has seen a decline of 3.4%, with shares opening at $18.86, significantly below its 12-month high of $26.09.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 27,860 shares of the company's stock, valued at approximately $625,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bessemer Group Inc. increased its holdings in shares of Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares during the period. Janney Montgomery Scott LLC boosted its holdings in shares of Privia Health Group by 4.6% during the 1st quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock worth $1,243,000 after buying an additional 2,413 shares during the period. GAMMA Investing LLC grew its stake in shares of Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after acquiring an additional 1,521 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock worth $27,687,000 after purchasing an additional 138,747 shares during the period. Finally, Teacher Retirement System of Texas acquired a new position in shares of Privia Health Group during the 1st quarter worth $387,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 3,322 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $24.99, for a total value of $83,016.78. Following the transaction, the chief financial officer owned 172,909 shares in the company, valued at $4,320,995.91. This trade represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Parth Mehrotra sold 13,773 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $24.99, for a total transaction of $344,187.27. Following the completion of the sale, the chief executive officer directly owned 423,143 shares of the company's stock, valued at approximately $10,574,343.57. This trade represents a 3.15% decrease in their position. The disclosure for this sale can be found here. 10.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on PRVA shares. Robert W. Baird boosted their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Needham & Company LLC restated a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. JPMorgan Chase & Co. lifted their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, May 28th. JMP Securities restated a "market outperform" rating and set a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. Finally, Truist Financial lifted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Privia Health Group presently has a consensus rating of "Buy" and an average target price of $28.38.

Privia Health Group Stock Up 1.6%

Shares of NASDAQ PRVA traded up $0.31 during trading on Wednesday, reaching $19.76. The company had a trading volume of 944,659 shares, compared to its average volume of 819,559. Privia Health Group, Inc. has a 12-month low of $16.47 and a 12-month high of $26.09. The business's 50-day moving average is $21.47 and its 200 day moving average is $22.88. The stock has a market cap of $2.41 billion, a PE ratio of 164.85, a P/E/G ratio of 3.12 and a beta of 0.80.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.